Status:
RECRUITING
A New Psychotherapy Intervention for Older Cancer Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Cancer
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
This study is being done to see if a new psychotherapy intervention called Cancer and Aging: Reflections for Elders (CARE) can effectively treat depression and distress in older cancer patients. CARE ...
Eligibility Criteria
Inclusion
- As per self-report or medical record, ≥ 70 years of age
- As per self-report or medical record, has a diagnosis of cancer
- As per self-report or medical record, receiving active treatment (e.g., radiation, chemotherapy, hormone); OR received active treatment in the past 6 months (N/A for training case participants); OR are currently on active surveillance with follow-ups at least approximately every 6 months
- Received a HADS-D score of ≥ 6 or HADS-A score of ≥ 6 or a score of ≥ 4 on the distress thermometer. (N/A for training case participants)
- Received a Karnofsky Performance Rating Scale (KPRS) score of ≥ 60 (N/A for training case participants)
- Received a Blessed Orientation-Memory-Concentration Scale (BOMC) score of ≤ 11 (N/A for training case participants)
- Fluent in English, as per self-reported fluency of "well" or "very well"\*
Exclusion
- As per self-report, currently taking antidepressant medication for \< 3 months
- As per self-report, currently receiving hospice care
- In the judgment of the consenting professional is unable to provide informed consent and complete study sessions and assessment
- As per self-report or as documented in the medical record, current untreated (e.g., no medication, no therapy) major psychotic disorder (schizotypal personality disorder, schizophreniform disorder, schizoaffective disorder). Patients diagnosed with a major psychiatric disorder will be reviewed by the study PI to determine eligibility prior to consent.
- Language verification: Prior to enrollment, patients will be asked the following two questions by research staff to verify English fluency necessary for participation in the study:
- How well do you speak English? (must respond "Well" or "Very well" when given the choices of Very well, Well, Not well, Not at all, Don't know, or Refused)
- What is your preferred language for healthcare? (must respond English)
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
459 Patients enrolled
Trial Details
Trial ID
NCT04452825
Start Date
February 1 2021
End Date
June 1 2026
Last Update
September 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065